Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 7Colorectal Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Skin Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thyroid Neoplasms 1Solid Tumor 1Rectal Diseases 1Neoplasms 1Lung Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Disease Progression 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1

Interventions

gadolinium ethoxybenzyl DTPA 1gadobutrol 1encorafenib 1durvalumab 1camrelizumab 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Irinotecan 1Immunotherapy 1Hydromorphone 1Fluorouracil 1Fentanyl 1Cetuximab 1Capecitabine 1Bupivacaine 1Blood Specimen Collection 1Biopsy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Digestive System Diseases × encorafenib × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡